LP-118

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF

Arms / Cohorts

Experimental:Multiple Myeloma Patients: Dose Escalation

Accepting patients

Experimental:MDS Patients: Dose Escalation

Accepting patients

Experimental:MDS/MPN Patients: Dose Escalation

Accepting patients

Experimental:Multiple Myeloma Patients: Dose Expansion

Not yet accepting

Experimental:MDS Patients: Dose Expansion

Not yet accepting

Experimental:MDS/MPN Patients: Dose Expansion

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.